awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q44006206-23150E9E-1C66-4493-B76E-422ECC6ACFA6
Q44006206-23150E9E-1C66-4493-B76E-422ECC6ACFA6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q44006206-23150E9E-1C66-4493-B76E-422ECC6ACFA6
An open-label study of thalidomide for maintenance therapy in responders to infliximab in chronically active and fistulizing refractory Crohn's disease.
P2860
Q44006206-23150E9E-1C66-4493-B76E-422ECC6ACFA6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q44006206-23150E9E-1C66-4493-B76E-422ECC6ACFA6
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
83779ad1f4d7a597c1a1c2ce8e30ad92876c39df
P2860
An open-label pilot study of low-dose thalidomide in chronically active, steroid-dependent Crohn's disease.